Key Highlights
- 11-Year Lease Signed: EBR Systems has secured a state-of-the-art, 51,000-square-foot facility in Santa Clara, California, under favorable lease terms.
- Manufacturing Growth: The facility will enhance corporate, R&D, and manufacturing capabilities for EBR’s WiSE device, supporting future growth.
- Strategic Transition: The move will be completed in H1 2026, with upgrades, installations, and regulatory inspections planned over the next year.
Details of the Expansion
- Progressive Lease Terms: Rent begins in January 2026 and phases in over four years, with full rent applicable from year four.
- Tenant Improvements: The landlord will finance approximately US$4M for upgrades, with EBR budgeting an additional US$1.3M for equipment and contingencies.
- Proximity Advantage: The new facility is just 4.2 km from the current headquarters in Sunnyvale, minimizing employee disruption.
CEO Commentary
John McCutcheon, President & CEO, stated:
“This facility is a pivotal step in transitioning EBR into a commercial medical device company addressing significant unmet needs. Its proximity ensures minimal disruption to employees, while its state-of-the-art features position us for scalable growth.”
Next Steps
- Complete facility upgrades and equipment installations in 2025.
- Undergo FDA Post-Approval Inspection (PAI) to ensure compliance with Quality System regulations.
- Transition staff and operations by H1 2026, closing the current Sunnyvale facility.
This strategic move solidifies EBR’s operational base in Silicon Valley, paving the way for sustained innovation and growth in the medical device sector.
